Heart Rhythm

Evaluation of age at symptom onset, proband status, and sex as predictors of disease severity in pediatric catecholaminergic polymorphic ventricular tachycardia.  18:1825-1832. 2021

Right ventricular insertion promotes reinitiation of ventricular fibrillation in defibrillation failure.  18:995-1003. 2021

Genetic testing in Polynesian long QT syndrome probands reveals a lower diagnostic yield and an increased prevalence of rare variants.  17:1304-1311. 2020

2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.  17:e2-e154. 2020

2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: Executive summary.  17:e155-e205. 2020

HRS 40th anniversary viewpoints: What's it all about?.  16:484-485. 2019

2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.  15:e73-e189. 2018

2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.  15:e190-e252. 2018

Early feasibility of hypoglossal nerve upper airway stimulator in patients with cardiac implantable electronic devices and continuous positive airway pressure-intolerant severe obstructive sleep apnea.  15:1165-1170. 2018

Albuminuria, kidney function, and sudden cardiac death: Findings from The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.  14:65-71. 2017

Cardiac implantable electronic device infection in patients with end-stage renal disease.  12:2395-2401. 2015

Clinical safety of the Iforia implantable cardioverter-defibrillator system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions.  12:2155-2161. 2015

Left atrial appendage electrical isolation and concomitant device occlusion: A safety and feasibility study with histologic characterization.  12:202-210. 2015

EHRA/HRS/APHRS Expert Consensus on Ventricular Arrhythmias.  11:e166-e196. 2014

Electrocardiography-inclusive screening strategies for detection of cardiovascular abnormalities in high school athletes.  11:442-449. 2014

Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.  10:1770-1777. 2013

Prevalence and clinical, electrocardiographic, and electrophysiologic characteristics of ventricular arrhythmias originating from the noncoronary sinus of Valsalva.  10:1605-1612. 2013

Noninvasive cardiac activation imaging of ventricular arrhythmias during drug-induced QT prolongation in the rabbit heart.  10:1509-1515. 2013

Effects of cardiac resynchronization therapy on left ventricular mass and wall thickness in mild heart failure patients in MADIT-CRT.  10:354-360. 2013

BIN1 is reduced and Cav1.2 trafficking is impaired in human failing cardiomyocytes.  9:812-820. 2012

Great cardiac venography by contrast injection through an external irrigation catheter.  9:156-157. 2012

Ionic mechanism of shock-induced arrhythmias: Role of intracellular calcium.  9:96-104. 2012

Left cardiac sympathetic denervation in a pediatric patient with hypertrophic cardiomyopathy and recurrent ventricular fibrillation.  8:1591-1594. 2011

Noninvasive imaging of three-dimensional cardiac activation sequence during pacing and ventricular tachycardia.  8:1266-1272. 2011

Prolongation of local ventriculoatrial conduction during left lateral accessory pathway ablation: What is the mechanism?.  8:942-943. 2011

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.  8. 2011

Novel intravascular defibrillator: Defibrillation thresholds of intravascular cardioverter-defibrillator compared to conventional implantable cardioverter-defibrillator in a canine model.  8:288-292. 2011

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines..  8:157-176. 2011

Commotio cordis: Size matters, so does shape.  8:1582-1583. 2011

HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. This document was developed in collaboration and endorsed by the American College of Cardiology (ACC), the American Geriatrics Society (AGS), the American Academy of Hospice and Palliative Medicine (AAHPM);.  7:1008-1026. 2010

Purkinje activation precedes myocardial activation following defibrillation after long-duration ventricular fibrillation.  7:405-412. 2010

Why do thrombi form in the left but not the right atrium in atrial fibrillation: Differences in platelet P-selectin levels?.  7:1184-1185. 2010

Complications during catheter ablation of atrial fibrillation: Identification and prevention.  6. 2009

Can mapping differentiate microreentry from a focus in the ventricle?.  6:1666-1669. 2009

How to diagnose and treat cardiac tamponade in the electrophysiology laboratory.  6:1531-1535. 2009

Implantable cardioverter-defibrillator prescription in the elderly.  6:1136-1143. 2009

EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias. Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA).  6:886-933. 2009

Transmural optical measurements of Vm dynamics during long-duration ventricular fibrillation in canine hearts.  6:796-802. 2009

Increased cycle length during long-duration ventricular fibrillation is caused by decreased upstroke velocity as well as prolonged refractoriness.  6:378-384. 2009

Mechanisms of VF maintenance: Wandering wavelets, mother rotors, or foci.  6:405-415. 2009

Idiopathic focal epicardial ventricular tachycardia originating from the crux of the heart.  6:44-50. 2009

Transmural recording of shock potential gradient fields, early postshock activations, and refibrillation episodes associated with external defibrillation of long-duration ventricular fibrillation in swine.  5:1599-1606. 2008

Progress in modeling cardiac electrical activity: A long way from spherical cows.  5:1045-1046. 2008

Successful catheter ablation of atrial fibrillation in a patient with cor triatriatum sinister.  5:903-904. 2008

Another advisory: Innovation, expectations, and balancing risks.  5:643-645. 2008

Focal atrial tachycardia originating from the epicardial left atrial appendage.  5:766-767. 2008

Electrocardiographic characteristics of ventricular arrhythmias originating from the junction of the left and right coronary sinuses of Valsalva in the aorta: The activation pattern as a rationale for the electrocardiographic characteristics.  5:184-192. 2008

Catheter ablation of ventricular arrhythmias originating in the vicinity of the His bundle: Significance of mapping the aortic sinus cusp.  5:37-42. 2008

Mechanistic insights into ventricular arrhythmias from mapping studies in humans.  5. 2008

Optical measurements of intramural action potentials in isolated porcine hearts using optrodes.  4:1430-1436. 2007

Electrophysiologic and electrocardiographic characteristics and radiofrequency catheter ablation of focal atrial tachycardia originating from the left atrial appendage.  4:1284-1291. 2007

Ventricular fibrillation: Discordant alternans and discordant results.  4:1069-1071. 2007

Transmural and endocardial Purkinje activation in pigs before local myocardial activation after defibrillation shocks.  4:758-765. 2007

Ventricular fibrillation: How do we put the genie back in the bottle?.  4:665-674. 2007

Intracardiac atrial defibrillation.  4. 2007

Atrial tachycardia originating from the noncoronary aortic cusp and musculature connection with the atria: Relevance for catheter ablation.  3:1494-1496. 2006

Focal atrial fibrillation originating from the coronary sinus musculature.  3:1088-1091. 2006

Role of intramural virtual electrodes in shock-induced activation of left ventricle: Optical measurements from the intact epicardial surface.  3:1063-1073. 2006

Electrophysiological pulmonary vein antrum isolation with a multielectrode basket catheter is feasible and effective for curing paroxysmal atrial fibrillation: Efficacy of minimally extensive pulmonary vein isolation.  3:377-384. 2006

The Sign of Four and the SDNN of one of three.  3:287-289. 2006

Decrease in fluoroscopic cardiac silhouette excursion precedes hemodynamic compromise in intraprocedural tamponade.  2:1224-1230. 2005

Quantification of activation patterns during ventricular fibrillation in open-chest porcine left ventricle and septum.  2:720-728. 2005

Should shocks still be administered during implantable cardioverter-defibrillator insertion?.  2:462-463. 2005

Ventricular fibrillation and defibrillation - What are the major unresolved issues?.  2:555-558. 2005

Activation sequences following failed atrial defibrillation.  1:616-623. 2004

Simple and accurate catheter mapping technique to predict atrial fibrillation foci in the pulmonary veins or posterior right atrium.  1:427-434. 2004

Prospective assessment after pediatric cardiac ablation: Recurrence at 1 year after initially successful ablation of supraventricular tachycardia.  1:188-196. 2004

Epicardial organization of human ventricular fibrillation.  1:14-23. 2004